ID   PPIB_HUMAN              Reviewed;         216 AA.
AC   P23284; A8K534; Q6IBH5; Q9BVK5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   28-JAN-2026, entry version 236.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase B;
DE            Short=PPIase B;
DE            EC=5.2.1.8 {ECO:0000269|PubMed:20676357};
DE   AltName: Full=CYP-S1;
DE   AltName: Full=Cyclophilin B;
DE   AltName: Full=Rotamase B;
DE   AltName: Full=S-cyclophilin;
DE            Short=SCYLP;
DE   Flags: Precursor;
GN   Name=PPIB; Synonyms=CYPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2040592; DOI=10.1016/s0021-9258(18)99078-2;
RA   Spik G., Haendler B., Delmas O., Mariller C., Chamoux M., Maes P.,
RA   Tartar A., Montreuil J., Stedman K., Kocher H.P., Keller R., Hiestand P.C.,
RA   Movva N.R.;
RT   "A novel secreted cyclophilin-like protein (SCYLP).";
RL   J. Biol. Chem. 266:10735-10738(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-216, AND PROTEIN SEQUENCE OF 34-48.
RX   PubMed=2000394; DOI=10.1073/pnas.88.5.1903;
RA   Price E.R., Zydowsky L.D., Jin M., Hunter C.H., McKeon F.D., Walsh C.T.;
RT   "Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl
RT   isomerase with a signal sequence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1903-1907(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-216.
RX   PubMed=1710767; DOI=10.1128/mcb.11.7.3484-3491.1991;
RA   Hasel K.W., Glass J.R., Godbout M., Sutcliffe J.G.;
RT   "An endoplasmic reticulum-specific cyclophilin.";
RL   Mol. Cell. Biol. 11:3484-3491(1991).
RN   [10]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.e02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein complexes in
RT   endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [11]
RP   PROTEIN SEQUENCE OF 52-59; 64-76; 91-101; 138-150; 164-172 AND 197-207, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   PROTEIN SEQUENCE OF 72-84 AND 159-165.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1530944; DOI=10.1083/jcb.116.1.113;
RA   Arber S., Krause K.-H., Caroni P.;
RT   "S-cyclophilin is retained intracellularly via a unique COOH-terminal
RT   sequence and colocalizes with the calcium storage protein calreticulin.";
RL   J. Cell Biol. 116:113-125(1992).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   INVOLVEMENT IN OI9.
RX   PubMed=19781681; DOI=10.1016/j.ajhg.2009.09.001;
RA   van Dijk F.S., Nesbitt I.M., Zwikstra E.H., Nikkels P.G., Piersma S.R.,
RA   Fratantoni S.A., Jimenez C.R., Huizer M., Morsman A.C., Cobben J.M.,
RA   van Roij M.H., Elting M.W., Verbeke J.I., Wijnaendts L.C., Shaw N.J.,
RA   Hogler W., McKeown C., Sistermans E.A., Dalton A., Meijers-Heijboer H.,
RA   Pals G.;
RT   "PPIB mutations cause severe osteogenesis imperfecta.";
RL   Am. J. Hum. Genet. 85:521-527(2009).
RN   [16]
RP   INTERACTION WITH MEASLES VIRUS NUCLEOPROTEIN (MICROBIAL INFECTION), AND
RP   SUBCELLULAR LOCATION (MICROBIAL INFECTION).
RX   PubMed=20147391; DOI=10.1128/jvi.02168-09;
RA   Watanabe A., Yoneda M., Ikeda F., Terao-Muto Y., Sato H., Kai C.;
RT   "CD147/EMMPRIN acts as a functional entry receptor for measles virus on
RT   epithelial cells.";
RL   J. Virol. 84:4183-4193(2010).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=20676357; DOI=10.1371/journal.pbio.1000439;
RA   Davis T.L., Walker J.R., Campagna-Slater V., Finerty P.J., Paramanathan R.,
RA   Bernstein G., MacKenzie F., Tempel W., Ouyang H., Lee W.H.,
RA   Eisenmesser E.Z., Dhe-Paganon S.;
RT   "Structural and biochemical characterization of the human cyclophilin
RT   family of peptidyl-prolyl isomerases.";
RL   PLoS Biol. 8:E1000439-E1000439(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   INTERACTION WITH DYM.
RX   PubMed=21280149; DOI=10.1002/humu.21413;
RA   Denais C., Dent C.L., Southgate L., Hoyle J., Dafou D., Trembath R.C.,
RA   Machado R.D.;
RT   "Dymeclin, the gene underlying Dyggve-Melchior-Clausen syndrome, encodes a
RT   protein integral to extracellular matrix and Golgi organization and is
RT   associated with protein secretion pathways critical in bone development.";
RL   Hum. Mutat. 32:231-239(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-216.
RX   PubMed=8197205; DOI=10.1073/pnas.91.11.5183;
RA   Mikol V., Kallen J., Walkinshaw M.D.;
RT   "X-ray structure of a cyclophilin B/cyclosporin complex: comparison with
RT   cyclophilin A and delineation of its calcineurin-binding domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5183-5186(1994).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 34-216 IN COMPLEX WITH CLGN,
RP   MUTAGENESIS OF LYS-129, AND INTERACTION WITH CALR; CANX AND CLGN.
RX   PubMed=20801878; DOI=10.1074/jbc.m110.160101;
RA   Kozlov G., Bastos-Aristizabal S., Maattanen P., Rosenauer A., Zheng F.,
RA   Killikelly A., Trempe J.F., Thomas D.Y., Gehring K.;
RT   "Structural basis of cyclophilin B binding by the calnexin/calreticulin P-
RT   domain.";
RL   J. Biol. Chem. 285:35551-35557(2010).
RN   [24]
RP   VARIANT OI9 ARG-9.
RX   PubMed=20089953; DOI=10.1056/nejmoa0907705;
RA   Barnes A.M., Carter E.M., Cabral W.A., Weis M., Chang W., Makareeva E.,
RA   Leikin S., Rotimi C.N., Eyre D.R., Raggio C.L., Marini J.C.;
RT   "Lack of cyclophilin B in osteogenesis imperfecta with normal collagen
RT   folding.";
RL   N. Engl. J. Med. 362:521-528(2010).
CC   -!- FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline
CC       imidic peptide bonds in oligopeptides and may therefore assist protein
CC       folding. {ECO:0000269|PubMed:20676357}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-peptidylproline (omega=180) = [protein]-
CC         peptidylproline (omega=0); Xref=Rhea:RHEA:16237, Rhea:RHEA-
CC         COMP:10747, Rhea:RHEA-COMP:10748, ChEBI:CHEBI:83833,
CC         ChEBI:CHEBI:83834; EC=5.2.1.8;
CC         Evidence={ECO:0000269|PubMed:20676357};
CC   -!- ACTIVITY REGULATION: Inhibited by cyclosporin A (CsA).
CC       {ECO:0000305|PubMed:20676357}.
CC   -!- SUBUNIT: Interacts with DYM. Interacts with CALR, CLGN and CANX. Part
CC       of a large chaperone multiprotein complex comprising DNAJB11, HSP90B1,
CC       HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB, SDF2L1, UGGT1 and very small
CC       amounts of ERP29, but not, or at very low levels, CALR nor CANX
CC       (PubMed:12475965). {ECO:0000269|PubMed:12475965,
CC       ECO:0000269|PubMed:20801878, ECO:0000269|PubMed:21280149}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with measles virus
CC       nucleoprotein. {ECO:0000269|PubMed:20147391}.
CC   -!- INTERACTION:
CC       P23284; Q8N9N5: BANP; NbExp=3; IntAct=EBI-359252, EBI-744695;
CC       P23284; Q7Z7K6: CENPV; NbExp=3; IntAct=EBI-359252, EBI-1210604;
CC       P23284; Q7RTS9: DYM; NbExp=4; IntAct=EBI-359252, EBI-2871106;
CC       P23284; Q06547-2: GABPB1; NbExp=3; IntAct=EBI-359252, EBI-618189;
CC       P23284; O43292-2: GPAA1; NbExp=3; IntAct=EBI-359252, EBI-25884370;
CC       P23284; Q9NWQ4-1: GPATCH2L; NbExp=3; IntAct=EBI-359252, EBI-11959863;
CC       P23284; P09017: HOXC4; NbExp=3; IntAct=EBI-359252, EBI-3923226;
CC       P23284; P17066: HSPA6; NbExp=3; IntAct=EBI-359252, EBI-355106;
CC       P23284; Q02363: ID2; NbExp=3; IntAct=EBI-359252, EBI-713450;
CC       P23284; Q8N5Z5: KCTD17; NbExp=3; IntAct=EBI-359252, EBI-743960;
CC       P23284; Q9Y4X4: KLF12; NbExp=3; IntAct=EBI-359252, EBI-750750;
CC       P23284; Q9H2C1: LHX5; NbExp=3; IntAct=EBI-359252, EBI-25835523;
CC       P23284; P13667: PDIA4; NbExp=2; IntAct=EBI-359252, EBI-1054653;
CC       P23284; P40855: PEX19; NbExp=6; IntAct=EBI-359252, EBI-594747;
CC       P23284; Q9NWS8-3: RMND1; NbExp=3; IntAct=EBI-359252, EBI-25884400;
CC       P23284; O43765: SGTA; NbExp=6; IntAct=EBI-359252, EBI-347996;
CC       P23284; Q96EQ0: SGTB; NbExp=4; IntAct=EBI-359252, EBI-744081;
CC       P23284; Q13586: STIM1; NbExp=3; IntAct=EBI-359252, EBI-448878;
CC       P23284; Q13061-2: TRDN; NbExp=3; IntAct=EBI-359252, EBI-17257686;
CC       P23284; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-741480;
CC       P23284; Q9UMX0-2: UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-10173939;
CC       P23284; Q9UHD9: UBQLN2; NbExp=5; IntAct=EBI-359252, EBI-947187;
CC       P23284; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-359252, EBI-12040603;
CC       P23284; A0A087WZY1; NbExp=3; IntAct=EBI-359252, EBI-13387614;
CC       P23284; PRO_0000037552 [Q9WMX2]; Xeno; NbExp=7; IntAct=EBI-359252, EBI-9005440;
CC       PRO_0000025479; P13667: PDIA4; NbExp=3; IntAct=EBI-8771982, EBI-1054653;
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000269|PubMed:20147391}.
CC       Note=(Microbial infection).
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:1530944}. Melanosome {ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from stage
CC       I to stage IV (PubMed:17081065). {ECO:0000269|PubMed:17081065}.
CC   -!- DISEASE: Osteogenesis imperfecta 9 (OI9) [MIM:259440]: A form of
CC       osteogenesis imperfecta, a disorder of bone formation characterized by
CC       low bone mass, bone fragility and susceptibility to fractures after
CC       minimal trauma. Disease severity ranges from very mild forms without
CC       fractures to intrauterine fractures and perinatal lethality.
CC       Extraskeletal manifestations, which affect a variable number of
CC       patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI9 is a severe autosomal recessive form of the disorder.
CC       {ECO:0000269|PubMed:19781681, ECO:0000269|PubMed:20089953}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase B
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-9 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52150.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database; Note=The
CC       PPIB gene homepage;
CC       URL="https://www.LOVD.nl/PPIB";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M63573; AAA36601.1; -; mRNA.
DR   EMBL; AK291149; BAF83838.1; -; mRNA.
DR   EMBL; CR456829; CAG33110.1; -; mRNA.
DR   EMBL; AY962310; AAX44050.1; -; Genomic_DNA.
DR   EMBL; AC100840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77669.1; -; Genomic_DNA.
DR   EMBL; BC001125; AAH01125.1; -; mRNA.
DR   EMBL; BC008848; AAH08848.1; -; mRNA.
DR   EMBL; BC020800; AAH20800.1; -; mRNA.
DR   EMBL; BC032138; AAH32138.1; -; mRNA.
DR   EMBL; M60857; AAA52150.1; ALT_INIT; mRNA.
DR   EMBL; M60457; AAA35733.1; -; mRNA.
DR   CCDS; CCDS10191.1; -.
DR   PIR; A39118; CSHUB.
DR   RefSeq; NP_000933.1; NM_000942.5.
DR   PDB; 1CYN; X-ray; 1.85 A; A=39-216.
DR   PDB; 3ICH; X-ray; 1.20 A; A=34-216.
DR   PDB; 3ICI; X-ray; 1.70 A; A/B=34-216.
DR   PDB; 8K0F; EM; 3.37 A; C=1-216.
DR   PDB; 8K0I; EM; 3.62 A; C/c=1-216.
DR   PDB; 8K0M; EM; 3.17 A; C=1-216.
DR   PDB; 8K17; EM; 3.18 A; C=1-216.
DR   PDB; 8KC9; EM; 3.75 A; C=1-216.
DR   PDBsum; 1CYN; -.
DR   PDBsum; 3ICH; -.
DR   PDBsum; 3ICI; -.
DR   PDBsum; 8K0F; -.
DR   PDBsum; 8K0I; -.
DR   PDBsum; 8K0M; -.
DR   PDBsum; 8K17; -.
DR   PDBsum; 8KC9; -.
DR   AlphaFoldDB; P23284; -.
DR   BMRB; P23284; -.
DR   EMDB; EMD-36763; -.
DR   EMDB; EMD-36765; -.
DR   EMDB; EMD-36774; -.
DR   EMDB; EMD-36787; -.
DR   EMDB; EMD-37097; -.
DR   SMR; P23284; -.
DR   BioGRID; 111475; 374.
DR   FunCoup; P23284; 2026.
DR   IntAct; P23284; 151.
DR   MINT; P23284; -.
DR   STRING; 9606.ENSP00000300026; -.
DR   BindingDB; P23284; -.
DR   ChEMBL; CHEMBL2075; -.
DR   DrugBank; DB04447; 1,4-Dithiothreitol.
DR   DrugBank; DB00172; Proline.
DR   DrugCentral; P23284; -.
DR   GlyConnect; 2943; 1 N-Linked glycan (1 site).
DR   GlyCosmos; P23284; 1 site, 2 glycans.
DR   GlyGen; P23284; 2 sites, 7 N-linked glycans (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; P23284; -.
DR   MetOSite; P23284; -.
DR   PhosphoSitePlus; P23284; -.
DR   SwissPalm; P23284; -.
DR   BioMuta; PPIB; -.
DR   DMDM; 215273869; -.
DR   OGP; P23284; -.
DR   REPRODUCTION-2DPAGE; IPI00646304; -.
DR   jPOST; P23284; -.
DR   MassIVE; P23284; -.
DR   PaxDb; 9606-ENSP00000300026; -.
DR   PeptideAtlas; P23284; -.
DR   PRIDE; P23284; -.
DR   ProteomicsDB; 54078; -.
DR   Pumba; P23284; -.
DR   TopDownProteomics; P23284; -.
DR   Antibodypedia; 2584; 521 antibodies from 35 providers.
DR   DNASU; 5479; -.
DR   Ensembl; ENST00000300026.4; ENSP00000300026.4; ENSG00000166794.8.
DR   GeneID; 5479; -.
DR   KEGG; hsa:5479; -.
DR   MANE-Select; ENST00000300026.4; ENSP00000300026.4; NM_000942.5; NP_000933.1.
DR   UCSC; uc002and.4; human.
DR   AGR; HGNC:9255; -.
DR   ClinPGx; PA33580; -.
DR   CTD; 5479; -.
DR   DisGeNET; 5479; -.
DR   GeneCards; PPIB; -.
DR   HGNC; HGNC:9255; PPIB.
DR   HPA; ENSG00000166794; Low tissue specificity.
DR   MalaCards; PPIB; -.
DR   MIM; 123841; gene.
DR   MIM; 259440; phenotype.
DR   OpenTargets; ENSG00000166794; -.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   VEuPathDB; HostDB:ENSG00000166794; -.
DR   eggNOG; KOG0880; Eukaryota.
DR   GeneTree; ENSGT00940000158007; -.
DR   HOGENOM; CLU_012062_4_2_1; -.
DR   InParanoid; P23284; -.
DR   OMA; ENHEITH; -.
DR   OrthoDB; 193499at2759; -.
DR   PAN-GO; P23284; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; P23284; -.
DR   BioCyc; MetaCyc:HS09452-MONOMER; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   PathwayCommons; P23284; -.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-9692916; SARS-CoV-1 activates/modulates innate immune responses.
DR   SignaLink; P23284; -.
DR   Agora; ENSG00000166794; -.
DR   BioGRID-ORCS; 5479; 16 hits in 1159 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; PPIB; human.
DR   EvolutionaryTrace; P23284; -.
DR   GeneWiki; PPIB; -.
DR   GenomeRNAi; 5479; -.
DR   Pharos; P23284; Tchem.
DR   PRO; PR:P23284; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P23284; protein.
DR   Bgee; ENSG00000166794; Expressed in stromal cell of endometrium and 213 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:AgBase.
DR   GO; GO:0032991; C:protein-containing complex; ISS:CAFA.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0016018; F:cyclosporin A binding; IBA:GO_Central.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0070063; F:RNA polymerase binding; IPI:AgBase.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0060348; P:bone development; IMP:UniProtKB.
DR   GO; GO:0044829; P:host-mediated activation of viral genome replication; IMP:AgBase.
DR   GO; GO:0044794; P:host-mediated activation of viral process; IMP:AgBase.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   CDD; cd01926; cyclophilin_ABH_like; 1.
DR   FunFam; 2.40.100.10:FF:000001; Peptidyl-prolyl cis-trans isomerase; 1.
DR   Gene3D; 2.40.100.10; Cyclophilin-like; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; 1.
DR   PANTHER; PTHR11071:SF477; PEPTIDYL-PROLYL CIS-TRANS ISOMERASE B; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; Cyclophilin-like; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Disease variant;
KW   Dwarfism; Endoplasmic reticulum; Glycoprotein; Isomerase;
KW   Osteogenesis imperfecta; Proteomics identification; Reference proteome;
KW   Rotamase; S-nitrosylation; Signal; Virion.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000269|PubMed:2000394"
FT   CHAIN           34..216
FT                   /note="Peptidyl-prolyl cis-trans isomerase B"
FT                   /id="PRO_0000025479"
FT   DOMAIN          47..204
FT                   /note="PPIase cyclophilin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00156"
FT   MOTIF           213..216
FT                   /note="Prevents secretion from ER"
FT   MOD_RES         84
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KR7"
FT   MOD_RES         165
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KR7"
FT   MOD_RES         202
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KR7"
FT   MOD_RES         209
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P24369"
FT   MOD_RES         209
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P24369"
FT   CARBOHYD        148
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         9
FT                   /note="M -> R (in OI9; patients have white sclerae, normal
FT                   dentition, no rhizomelia or severe deformity of long bones;
FT                   dbSNP:rs137853864)"
FT                   /evidence="ECO:0000269|PubMed:20089953"
FT                   /id="VAR_063436"
FT   VARIANT         60
FT                   /note="V -> L (in dbSNP:rs11558595)"
FT                   /id="VAR_047711"
FT   MUTAGEN         129
FT                   /note="K->A: Impairs interaction with CLGN and CANX."
FT                   /evidence="ECO:0000269|PubMed:20801878"
FT   CONFLICT        5
FT                   /note="S -> R (in Ref. 8; AAA52150)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216
FT                   /note="E -> D (in Ref. 3; CAG33110)"
FT                   /evidence="ECO:0000305"
FT   STRAND          41..52
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          55..64
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   HELIX           70..81
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   TURN            82..84
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   TURN            98..100
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          101..104
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   TURN            107..109
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          110..113
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          118..121
FT                   /evidence="ECO:0007829|PDB:8K0M"
FT   STRAND          137..140
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:1CYN"
FT   STRAND          152..157
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   TURN            163..165
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   HELIX           176..183
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:3ICH"
FT   STRAND          197..212
FT                   /evidence="ECO:0007829|PDB:3ICH"
SQ   SEQUENCE   216 AA;  23743 MW;  2D0410A07AA9E420 CRC64;
     MLRLSERNMK VLLAAALIAG SVFFLLLPGP SAADEKKKGP KVTVKVYFDL RIGDEDVGRV
     IFGLFGKTVP KTVDNFVALA TGEKGFGYKN SKFHRVIKDF MIQGGDFTRG DGTGGKSIYG
     ERFPDENFKL KHYGPGWVSM ANAGKDTNGS QFFITTVKTA WLDGKHVVFG KVLEGMEVVR
     KVESTKTDSR DKPLKDVIIA DCGKIEVEKP FAIAKE
//
